A stage I study in Japanese patients with R/R NHL, together with ATLL clients, showed a workable safety profile, and forty mg twice each week was chosen for subsequent medical progress. These preclinical observations assist the speculation that tucidinostat might be efficacious in ATLL. Olsen EA, Whittaker S, Kim YH, et https://owenh554tep7.aboutyoublog.com/profile